These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2843240)

  • 41. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C; Korichneva I; Devynck MA
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of prostaglandin synthetase substrate analogues. 2. (8Z,11Z,14Z)-15-Methyl-8,11,14-eicosatrienoic acid.
    Dawson MI; Reid M; Hemler ME; Lands WE
    J Med Chem; 1977 Nov; 20(11):1396-400. PubMed ID: 410929
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolism of 8,11,14-eicosatrienoic acid in human platelets.
    Falardeau P; Hamberg M; Samuelsson B
    Biochim Biophys Acta; 1976 Aug; 441(2):193-200. PubMed ID: 952987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism of 5,6-epoxyeicosatrienoic acid by the human platelet. Formation of novel thromboxane analogs.
    Balazy M
    J Biol Chem; 1991 Dec; 266(35):23561-7. PubMed ID: 1748634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets.
    Lagarde M; Drouot B; Guichardant M; Dechavanne M
    Biomed Biochim Acta; 1984; 43(8-9):S319-22. PubMed ID: 6097236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS; Jones RL
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.
    Murray KJ; England PJ; Hallam TJ; Maguire J; Moores K; Reeves ML; Simpson AW; Rink TJ
    Br J Pharmacol; 1990 Mar; 99(3):612-6. PubMed ID: 2158847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological activity of epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells.
    Rosolowsky M; Falck JR; Campbell WB
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():213-6. PubMed ID: 1825542
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids.
    Guichardant M; Lagarde M
    Biochim Biophys Acta; 1985 Sep; 836(2):210-4. PubMed ID: 3927982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. II. Effects of vitamin C.
    Manku MS; Oka M; Horrobin DF
    Prostaglandins Med; 1979 Aug; 3(2):129-37. PubMed ID: 552100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The identification of an epoxy-hydroxy acid as a product from the incubation of arachidonic acid with washed blood platelets.
    Walker IC; Jones RL; Wilson NH
    Prostaglandins; 1979 Aug; 18(2):173-8. PubMed ID: 523677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids.
    Croset M; Lagarde M
    Biochem Biophys Res Commun; 1983 May; 112(3):878-83. PubMed ID: 6405751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. I. Effects of ethanol.
    Manku MS; Oka M; Horrobin DF
    Prostaglandins Med; 1979 Aug; 3(2):119-28. PubMed ID: 552099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin precursors in platelet phosphoglycerides following acute myocardial infarction.
    Roshanai F; Sanders T; Howarth D; Haines A
    Thromb Res; 1981 Oct 1-15; 24(1-2):169-73. PubMed ID: 6277036
    [No Abstract]   [Full Text] [Related]  

  • 60. The structure-activity relationship of lipoxygenase products of long-chain polyunsaturated fatty acids: effects on human platelet aggregation.
    Karanian JW; Kim HY; Salem N
    Lipids; 1996 Mar; 31 Suppl():S305-8. PubMed ID: 8729140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.